Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis

Hee-Chul SHIN; Wonshik HAN; Hyeong-Gon MOON; In-Ae PARK; Dong-Young NOH.
Journal of Breast Cancer ; : 268-274, 2016.
Artículo en Inglés | WPRIM | ID: wpr-126243

Documentos relacionados

  1. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
  2. [Effect of progesterone on expression of ER, PR, PCNA, bcl-2, c-myc, c-fos, and EGFR in normal breast tissue implanted into nude mice].
  3. Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution.
  4. GALNT8 suppresses breast cancer cell metastasis potential by regulating EGFR O-GalNAcylation.
  5. Revealing Novel Source of Breast Cancer Inhibitors from Seagrass <i>Enhalus acoroides</i>: In Silico and In Vitro Studies.
  6. Migratory Tumor Cells Cooperate with Cancer Associated Fibroblasts in Hormone Receptor-Positive and HER2-Negative Breast Cancer.
  7. Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort.
  8. Ethnic differences in the receptors status of estrogen, progesterone and Her2/Neu among breast cancer women: A single institution experience.
  9. Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry.
  10. Breast cancer survival by immunohistochemistry-determined subtype: A retrospective study.